P-ISSN 2587-2400 | E-ISSN 2587-196X
Ejmo Kapak
EJMO Volume : 8 Issue : 3 Year : 2024
COVID-19 in EJMO 8/3EJMO Current Issue EJMO Archive EJMO & Congress Most Cited Articles Ahead of Print
Copyright Transfer Form
ICMJE COI Form

Volume: 5 Issue: 4 - 2021

SYSTEMATIC REVIEW
Treatment Protocols and Outcomes of Intraoperative Radiotherapy for Brain Metastases: A Systematic Review
Juan Silvestre G. Pascual, Ella Mae D. Cruz-Lim, Aveline Marie D. Ylanan, Katrina Hannah D. Ignacio, Johanna Patricia A. Cańal, Kathleen Joy O. Khu
doi: 10.14744/ejmo.2021.29249   Pages  281 -  290 
(Viewed: 2420)
RESEARCH ARTICLE
Association of MATN-3 and ADIPOQ Polymorphisms with Susceptibility to Knee Osteoarthritis
Ahmad Hashemzehi, Mohammadamin Ghadyani, Seyed Alireza Dastgheib, Mohammed Reza Sobhan, Sepideh Setayesh, Seyedali Salari, Masoud Zare-Shehneh, Karim Daliri, Hossein Neamatzadeh
doi: 10.14744/ejmo.2021.23898   Pages  291 -  297 
(Viewed: 2202)
Metformin Eliminates CD133high/CD44high Prostate Cancer Stem Cells Via Cell Cycle Arrest and Apoptosis
Eda Acikgoz, Mustafa Cakir, Mustafa Guven, Gulperi Oktem
doi: 10.14744/ejmo.2021.11927   Pages  298 -  304 
(Viewed: 2294)
Chest X-Ray Scoring System in COVID-19 Pneumonia: An Added Value in the Evaluation of the Disease Severity
Marco Fogante, Enrico Cavagna, Giovanni Rinaldi
doi: 10.14744/ejmo.2021.70171   Pages  305 -  310 
(Viewed: 2283)
Relevance of Inflammatory Biomarkers in Salivary Gland Cancers Management
Vincenzo Abbate, Giovanni Dell Aversana Orabona, Simona Barone, Stefania Troise, Paola Bonavolontŕ, Daniela Pacella, Giorgio Iaconetta, Luigi Califano
doi: 10.14744/ejmo.2021.85983   Pages  311 -  317 
(Viewed: 2421)
The Angiotensin-Converting Enzyme Inhibitor ‘Enalapril’ Increases the Anti-Proliferative Activity of 5-Fluorouracil in Colorectal Cancer Cells
Asma Mostafapour, Javad Baharara, Majid Khazaei, Amir Avan, Seyed Mahdi Hassanian
doi: 10.14744/ejmo.2021.60832   Pages  318 -  326 
(Viewed: 2240)
Prognostic Importance of DUSP22 (Dual Specificity Phosphatase 22) Gene Expression in Low-Grade Lymphomas
Semra Paydas, Emine Kilic Bagir, Melek Ergin, Gulsah Seydaoglu, Mahmut Buyuksimsek, Asli Boz
doi: 10.14744/ejmo.2021.59080   Pages  327 -  331 
(Viewed: 2059)
Adhesive Glue vs Subcuticular Sutures for Cesarean Section Skin Closure: A Double Blind Randomized Controlled Trial
Hafizur Rahman, Ezzat Khalda
doi: 10.14744/ejmo.2021.12232   Pages  332 -  340 
(Viewed: 2145)
The Effects of a Health Literacy Training Intervention on Self-Care Behaviors and Treatment Adherence in Patients with Ischemic Heart Diseases
Zeynab Hakimzadeh, Mohsen Adib Hajbaghery
doi: 10.14744/ejmo.2021.61673   Pages  341 -  349 
(Viewed: 1918)
Chemomodulatory Effect of Capsaicin Encapsulated Chitosan Nanoparticles on Lipids, Lipoproteins and Glycoprotein Components in DMBA Induced Mammary Carcinogenesis in Rats
Kalaiyarasi Dhamodharan, Manobharathi Vengaimaran, Mirunalini Sankaran
doi: 10.14744/ejmo.2021.61180   Pages  350 -  357 
(Viewed: 1735)
CASE REPORT
Atypical Chronic Myeloid Leukemia: Case Report and Review of Literature
Brittany Miles, Nicholas Martinez, Khaled Atieh, James Mackey
doi: 10.14744/ejmo.2021.24484   Pages  358 -  360 
(Viewed: 1990)
Sarcomatoid Transformation of Cromophobe Renal Cell Carcinoma: An Unusual Pathology. Our Experience, Definition of Therapeutic Guidelines and Review of Literature
Irene De La Parra, Álvaro Serrano, Roser Vives, Juan Hermida, Luis Ignacio Diez-Valladares, Jerónimo Barrera, José Antonio Cortés, Pilar González-Peramato, Ángel Gómez, Jesús Moreno
doi: 10.14744/ejmo.2021.47478   Pages  361 -  367 
(Viewed: 1783)
LETTER TO THE EDITOR
Surrogate Indicators of Overall Survival in Advanced Hepatocellular Carcinoma
Hao-Tian Liu, Yu-Hong Sun, Zhu-Jian Deng, Zi-Yi Zhang, Da-Long Yang, Kun-Jun Wu, Xiao-Bu Lan
doi: 10.14744/ejmo.2021.21883   Pages  368 -  370 
(Viewed: 1750)
Patient on Antithrombotics Drugs: Communication Between the Dentist and the Physician
Saibaba Mahalakshmi, Suhas Setty, Hariyabbe Rangaswamy Likhithaswamy
doi: 10.14744/ejmo.2021.65852   Pages  371 -  373 
(Viewed: 1879)

Submit Manuscript
WEB OF SCIENCE click

  • Impact Factor: 2.5

  • Medicine, General & Internal: Q2 146/322


    • SCOPUS click

  • CiteScoreTracker 2023: 3.6
  • CiteScore year 2022:
    0.9
  • CiteScore year 2021:
    0.2


    • Google Scholar click

  • Number of Articles:315
  • Citations:2587
  • h-index:16
  • i10-index:=26

  • EJMO NLM ID: 101720527

  • Accept Ratio :18.2 %
  • Final decision avg 34 day

    • Copyright © 2024 Eurasian Journal of Medicine and Oncology, EJMO

    EJMO & EJMO